Literature DB >> 24485156

Diagnosis and classification of Kawasaki disease.

Judith Sánchez-Manubens1, Rosa Bou2, Jordi Anton3.   

Abstract

Kawasaki disease is an acute systemic vasculitis of unknown etiology. Diagnosis is based on clinical criteria that include fever, exanthema, conjunctivitis, changes in the extremities, erythema of oral mucosa and lips and cervical lymphadenopathy. However, these criteria have low sensitivity and specificity and therefore, other clinical and laboratory features may be helpful in establishing the diagnosis, especially for cases of atypical or incomplete Kawasaki disease. Prognosis depends on the extent of cardiac involvement; coronary aneurysms develop in 20-25% of untreated patients and these may lead to myocardial infarction and sudden death. Treatment with high-dose intravenous immunoglobulin is effective in reducing the risk of coronary aneurysms in most cases and is the treatment of choice for initial Kawasaki disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Child; Coronary aneurysm; Fever; Intravenous immunoglobulins; Mucocutaneous lymph node syndrome

Mesh:

Substances:

Year:  2014        PMID: 24485156     DOI: 10.1016/j.jaut.2014.01.010

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  24 in total

1.  Incomplete Kawasaki disease with coronary artery aneurysm and coronary sinus thrombus.

Authors:  Guang Song; Weidong Ren; Zhe Liu; Dan Wu
Journal:  Pediatr Cardiol       Date:  2015-03-12       Impact factor: 1.655

2.  N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.

Authors:  Hyuksool Kwon; Jin Hee Lee; Jae Yun Jung; Young Ho Kwak; Do Kyun Kim; Jin Hee Jung; Ikwan Chang; Kyuseok Kim
Journal:  Eur J Pediatr       Date:  2016-10-31       Impact factor: 3.183

3.  Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.

Authors:  Judith Sánchez-Manubens; Jordi Antón; Rosa Bou; Estíbaliz Iglesias; Joan Calzada-Hernandez; Sergi Borlan; Clara Gimenez-Roca; Josefa Rivera
Journal:  Rheumatol Int       Date:  2016-05-23       Impact factor: 2.631

4.  ST-elevation myocardial infarction in a young adult secondary to giant coronary aneurysm thrombosis: an important sequela of Kawasaki disease and a management challenge.

Authors:  Elizabeth L Potter; Ian T Meredith; Peter James Psaltis
Journal:  BMJ Case Rep       Date:  2016-01-20

Review 5.  Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.

Authors:  Yu-Qing Xie; Hong-Di Ma; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 6.  Diagnostic approach and current treatment options in childhood vasculitis.

Authors:  Kenan Barut; Sezgin Şahin; Amra Adroviç; Özgür Kasapçopur
Journal:  Turk Pediatri Ars       Date:  2015-12-01

7.  Thrombosis in vasculitis: from pathogenesis to treatment.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Amedeo Amedei; Elena Niccolai; Mario Milco D'Elios; Chiara Della Bella; Alessia Grassi; Matteo Becatti; Claudia Fiorillo; Lorenzo Emmi; Augusto Vaglio; Domenico Prisco
Journal:  Thromb J       Date:  2015-04-16

8.  Extensive cervical lymphadenitis mimicking bacterial adenitis as the first presentation of Kawasaki disease.

Authors:  Felipe de Souza Rossi; Marco Felipe Castro da Silva; Kátia Tomie Kozu; Luís Fernando Aranha Camargo; Flávia Feijó Panico Rossi; Clovis Artur Silva; Lúcia Maria de Arruda Campos
Journal:  Einstein (Sao Paulo)       Date:  2015-06-30

9.  Kawasaki disease and hepatobiliary involvement: report of two cases.

Authors:  Ingeborg Marianne Keeling; Elisabeth Beran; Otto Eugen Dapunt
Journal:  Ital J Pediatr       Date:  2016-03-08       Impact factor: 2.638

10.  MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease.

Authors:  Chaowu Liu; Deguang Yang; Hong Wang; Shengwei Hu; Xiaofei Xie; Li Zhang; Hongling Jia; Qi Qi
Journal:  Mol Cell Biochem       Date:  2021-08-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.